Xeris Biopharma Holdings (XERS) Amortization - Intangibles (2021 - 2026)
Xeris Biopharma Holdings (XERS) recorded Amortization - Intangibles of $2.71 million in Q2 2026, unchanged from $2.71 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Amortization - Intangibles (2021 - 2026) Analysis & Trends
On a TTM basis, Xeris Biopharma Holdings' Amortization - Intangibles came in at $10.84 million as of Jun 30, 2026, unchanged year-over-year; for FY2025, it came in at $10.84 million, unchanged from FY2024.
- Annual Amortization - Intangibles has a four-year compound annual growth rate of 110.7% (FY2021 to FY2025).
- Across earlier years, Amortization - Intangibles came in at $10.84 million in FY2024 (unchanged), $10.84 million in FY2023 (unchanged), $10.84 million in FY2022 and $550,000 in FY2021.
- Across the past five years, year-over-year growth in Amortization - Intangibles ran from 0.0% in Q1 2025 to 392.9% in Q4 2022.
- Per Business Quant, the preceding three quarters came in at $2.71 million (Q1 2026), $2.71 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Xeris Biopharma Holdings | 1.61 Bn | 1.17 Bn | 79.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.71 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 550,000.00 |
API Access
Xeris Biopharma Holdings Amortization - Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-intangibles", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();